Cargando…
APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy
Tumor-associated neo-antigens are mutated peptides that allow the immune system to recognize the affected cell as foreign. Cells carrying excessive mutation load often develop mechanisms of tolerance. PD-L1/PD-1 checkpoint immunotherapy is a highly promising approach to overcome these protective sig...
Autores principales: | Boichard, Amélie, Pham, Timothy V., Yeerna, Huwate, Goodman, Aaron, Tamayo, Pablo, Lippman, Scott, Frampton, Garrett M., Tsigelny, Igor F., Kurzrock, Razelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350681/ https://www.ncbi.nlm.nih.gov/pubmed/30723579 http://dx.doi.org/10.1080/2162402X.2018.1550341 |
Ejemplares similares
-
Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy
por: Pham, Timothy V., et al.
Publicado: (2020) -
High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations
por: Boichard, Amélie, et al.
Publicado: (2017) -
Therapeutic implications of cancer gene amplifications without mRNA overexpression: silence may not be golden
por: Boichard, Amélie, et al.
Publicado: (2021) -
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials
por: Galanina, Natalie, et al.
Publicado: (2018) -
Intra-patient stability of tumor mutational burden from tissue biopsies at different time points in advanced cancers
por: Pham, Timothy V., et al.
Publicado: (2021)